Hormone use postmenopausal women
Common Questions and Answers about Hormone use postmenopausal women
hormone
As long as they increase - they are good! Look at some of the threads in this forum - a bunch of women posted their levels - but you cant compare apples to apples since you don't know exactly when you conceived. Just make sure they are increasing through another blood test to be sure.
Another consideration in regard to HRT:
Two studies reported in April at the American Assn. for Cancer Research 101st Annual Meeting 2010 found that if a woman's breast density changes, so does her risk of breast cancer — if density goes up, so does risk, and vice versa.
Tamoxifen is a hormone therapy that blocks estrogen to breast tissue. It is the hormone that is recommended for women with ER/PR positive breast cancer who are premenopausal or postmenopausal. Arimidex (or other aromatase inhibitors) is another class of hormone therapy that also blocks estrogen to breast tissue but these drugs are only offered to women who are postmenopausal. Both tamoxifen and armidex only address the ER/PR status and do not have any impact on CerbB2.
There is nothing wrong with you at all. A majority of 39 year old women have regular monthly periods. At that age hormone levels are all over the map. I would say that you are peri-menopausal, and that you will stop having periods earlier than later, but I wouldn't hazard a guess as to when that will be.
Some medications can cause elevations in HCG, as can some cysts and tumors (especially ovarian tumors). Also, it can be elevated in some postmenopausal women.
A recent study confirmed the long-term superior efficacy and safety of anastrozole (Arimidex) over tamoxifen as initial adjuvant therapy for postmenopausal women with hormone-sensitive early breast cancer.
It is apparently considered likely that this would hold true for the other AIs, such as Aromasin, but if you wish, you could ask your doctor about the possibility of trying Arimidex in place of Aromasin.
Best wishes...
, locoregional or distant recurrence or contralateral breast cancer), postmenopausal women with hormone receptor–positive breast cancer should consider an AI, either as primary adjuvant therapy for 5 years or sequentially after 2 to 3 years of tamoxifen to yield a total of 5 years of adjuvant endocrine therapy. Women who discontinue initial AI therapy before 5 years should consider using tamoxifen to bring the total duration of adjuvant therapy to 5 years.
s plenty of confusion about hormone replacement therapy, which is now commonly called hormone therapy. The truth is that hormone therapy is not a magical cure , but it's still the most effective treatment for unpleasant menopausal symptoms for most women.
Estrogen remains the most effective treatment for relief of troublesome menopausal hot flashes and night sweats. It can also ease vaginal symptoms of menopause, such as dryness, itching, burning and discomfort with intercourse.
My doc did not go over the side effects of these but when I looked up Duavee it looked like hormone meds had severe side effects, one being particularly important to women, the increased risk of uteurus cancer.
I guess I read that some take progestins with it to help decrease the risks of uterus cancer, but on the warning it says not to mix any additional estrogens or progestins together. Are these meds worth the benefits over the cons? Looking forward to hearing your thoughts.
Our results support experimental data and have important clinical implications for the management of postmenopausal women. These results suggest that HRT is safe and potentially beneficial with respect to liver fibrosis.
In conclusion, in our population of women with chronic hepatitis C, fibrosis progression was associated with known risk factors, particularly higher BMI and longer duration of infection. The menopause seems to have a negative role, accelerating fibrosis progression.
NEW YORK (Reuters Health) - After approximately 8 years, postmenopausal women with hormone-sensitive breast cancer who received (Arimidex), generically known as anastrazole, had a lower risk of recurrence than women taking tamoxifen, investigators reported at the annual meeting of the San Antonio Breast Cancer Symposium.
After an average of 68 months, women on Arimidex had a 15-percent greater disease-free survival and a 25-percent longer time to disease recurrence than women on tamoxifen.
Ovarian ablation can be accomplished by ovarian irradiation, surgery, or use of gonadotropin hormone-releasing hormone (GnRH) and leutenizing hormone-releasing hormone (LHRH) agonists. This can decrease the risk of breast cancer recurrence and mortality.
The reason why your cancer is inoperable is probably because of the extent of disease. You mentioned that you have several spots in the neck and lungs. It would be impossible to remove all involved tissues.
s almost as if the AP does not give as much protection during that time. By day 2 of period things are back to normal. There is a link between the lowering of hormone level just before menstruation and mood and the GP suggested that I went of the contraceptive injection / implant.
Lichen sclerosus is a chronic disease which effects usually the genital areas in postmenopausal women. The exact cause is not known and can be too active immune system and hormone problems. I suggest you to get it evaluated from a dermatologist and get the diagnosis confirmed. Biopsy skin may be needed for this.
It is very difficult to precisely confirm a diagnosis without examination and investigations and the answer is based on the medical information provided.
I know that postmenopausal women are able to breastfeed. My understanding of breastfeeding is that it happens as a result of nipple stimulation, and although the hormones secreted from the placenta are the easiest ways to kickstart it, adoptive mothers and even the occasional man have been able to stimulate their nipples into producing milk without hormones.
Recommended
